List of Excipients in API dopamine hci
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dopamine hci
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | DOPAMINE HCI | dopamine hci | 51662-1220 | ANHYDROUS CITRIC ACID | |
| HF Acquisition Co. LLC, DBA Health First | DOPAMINE HCI | dopamine hci | 51662-1220 | SODIUM METABISULFITE | |
| HF Acquisition Co. LLC, DBA Health First | DOPAMINE HCI | dopamine hci | 51662-1220 | TRISODIUM CITRATE DIHYDRATE | |
| HF Acquisition Co LLC, DBA HealthFirst | DOPAMINE HCI | dopamine hci | 51662-1291 | ANHYDROUS CITRIC ACID | |
| HF Acquisition Co LLC, DBA HealthFirst | DOPAMINE HCI | dopamine hci | 51662-1291 | SODIUM METABISULFITE | |
| HF Acquisition Co LLC, DBA HealthFirst | DOPAMINE HCI | dopamine hci | 51662-1291 | TRISODIUM CITRATE DIHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for dopamine hci
Excipient focus: ANHYDROUS CITRIC ACID
dopamine hci drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE MONOHYDRATE
dopamine hci drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
dopamine hci drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
dopamine hci drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
dopamine hci drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
dopamine hci drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dopamine hci drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci in 5% dextrose | 51662-1458 |
| >Company | >Ingredient | >NDC |
dopamine hci drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co. LLC, DBA Health First | dopamine hci | 51662-1220 |
| HF Acquisition Co LLC, DBA HealthFirst | dopamine hci | 51662-1291 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
